Skip to product information
1 of 1
Sale

Piracovi 200 (Molnupiravir 200 mg) – Buy Online

Piracovi 200 (Molnupiravir 200 mg) – Buy Online

1000 in stock

SKU:MPH-PIRACOVI200-STANDARD-TABLET-40TABLET

Regular price $175.00 USD
Regular price $195.00 USD Sale price $175.00 USD
Pack Size
  • Free Shipping & Returns on this item
  • Delivery within 3-5 working days
View full details

What is Piracovi 200 (Molnupiravir 200 mg)?

Piracovi 200 (Molnupiravir 200 mg) (Molnupiravir 200mg Tablet) is a clinically trusted prescription tablet for mild to moderate COVID-19 in at-risk adults. Available at MedsPrimeHub with discreet shipping to USA, UK, and Canada.

Uses of Piracovi 200 (Molnupiravir 200 mg)

  • COVID-19 treatment in high-risk non-hospitalised adults
  • Early antiviral intervention within 5 days of symptom onset
  • Reduction of SARS-CoV-2 viral load
  • COVID-19 in immunocompromised patients

Always follow your doctor's instructions and complete the full course of treatment.

How It Works

Piracovi 200 (Molnupiravir 200 mg) (Molnupiravir 200mg Tablet) acts as a ribonucleoside analogue incorporated into viral RNA during SARS-CoV-2 replication, introducing lethal mutations and preventing production of functional viral progeny through error catastrophe. Treatment should be initiated as early as possible for best results.

Dosage

Dosage is determined by your prescriber based on infection type, severity and individual patient factors. Always take exactly as directed.

Side Effects

Commonly reported side effects include:

  • Nausea and diarrhoea
  • Headache
  • Dizziness
  • Elevated transaminases
  • Rash
  • Fatigue

Contact your doctor immediately if you experience severe or unusual symptoms.

Benefits

Piracovi 200 (Molnupiravir 200 mg) provides a clinically validated treatment for mild to moderate COVID-19 in at-risk adults. Available at competitive prices from MedsPrimeHub with fast, discreet delivery worldwide.

Precautions

  • Must begin within 5 days of COVID-19 symptom onset
  • Not for use in pregnancy — significant teratogenic risk
  • Male patients should use contraception for 3 months after treatment
  • Do not use for prevention of COVID-19

Store at 15–25°C away from moisture and sunlight. Keep out of reach of children.

Disclaimer: For educational purposes only. Always consult a licensed healthcare provider before starting or modifying any medication.